DEUTSCHE BANK AG\ - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 118 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.92 and the average weighting 1.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$137,229
-88.4%
43,290
-81.7%
0.00%
-100.0%
Q2 2023$1,178,218
-46.8%
237,066
-47.1%
0.00%0.0%
Q1 2023$2,212,873
-21.3%
447,950
+0.3%
0.00%
-50.0%
Q4 2022$2,810,058
-40.8%
446,750
+1.6%
0.00%
-33.3%
Q3 2022$4,750,000
-14.6%
439,811
-9.8%
0.00%0.0%
Q2 2022$5,559,000
+56.9%
487,631
+25.4%
0.00%
+50.0%
Q1 2022$3,542,000
-31.1%
388,766
+12.8%
0.00%0.0%
Q4 2021$5,140,000
-5.5%
344,526
+62.8%
0.00%
-33.3%
Q3 2021$5,438,000
-10.8%
211,589
-9.5%
0.00%0.0%
Q2 2021$6,097,000
-13.6%
233,783
+16.9%
0.00%
-25.0%
Q1 2021$7,058,000
+7.2%
199,951
-23.4%
0.00%0.0%
Q4 2020$6,586,000
+218.6%
260,918
+376.0%
0.00%
+300.0%
Q3 2020$2,067,000
-25.3%
54,819
-15.2%
0.00%
-50.0%
Q2 2020$2,767,000
+831.6%
64,614
+323.3%
0.00%
Q1 2020$297,000
-38.9%
15,263
-18.7%
0.00%
Q4 2019$486,000
+55.8%
18,775
+63.5%
0.00%
Q3 2019$312,000
-46.4%
11,484
-47.2%
0.00%
Q2 2019$582,000
-50.4%
21,764
-46.5%
0.00%
-100.0%
Q1 2019$1,174,000
+17.0%
40,714
+9.2%
0.00%0.0%
Q4 2018$1,003,00037,3000.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$26,829,00010.04%
Wildcat Capital Management, LLC 1,716,370$25,608,0004.17%
TPG GP A, LLC 18,716,306$279,247,0002.79%
Casdin Capital, LLC 2,650,000$39,538,0001.11%
Lombard Odier Asset Management (Switzerland) SA 996,116$14,862,0000.95%
Coastal Bridge Advisors, LLC 301,929$4,505,0000.94%
HARBOR CAPITAL ADVISORS, INC. 119,547$1,784,0000.65%
Pier Capital, LLC 294,968$4,401,0000.46%
Navalign, LLC 64,428$961,0000.38%
Gratus Capital, LLC 191,871$2,863,0000.26%
View complete list of ALLOGENE THERAPEUTICS INC shareholders